Pelthos Therapeutics, Inc. (PTHS)
22.19
-0.21
(-0.94%)
USD |
NYAM |
Sep 25, 16:00
22.34
+0.14
(+0.65%)
After-Hours: 19:59
Pelthos Therapeutics Net Income (TTM) : -86.39M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -86.39M |
| March 31, 2026 | -66.42M |
| December 31, 2025 | -43.32M |
| September 30, 2025 | -23.35M |
| June 30, 2025 | -8.883M |
| March 31, 2025 | -7.996M |
| September 30, 2024 | -10.07M |
| Date | Value |
|---|---|
| June 30, 2024 | -9.795M |
| March 31, 2024 | -8.977M |
| December 31, 2023 | -7.381M |
| September 30, 2023 | -4.081M |
| June 30, 2023 | -3.216M |
| March 31, 2023 | -2.597M |
| December 31, 2022 | -1.941M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Travere Therapeutics, Inc. | -67.68M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Anika Therapeutics, Inc. | -3.121M |
| Savara, Inc. | -139.31M |